MEDecision Enters Agreement With Blue Cross and Blue Shield of Florida
30 4์ 2008 - 8:30PM
Business Wire
MEDecision, Inc. (Nasdaq: MEDE), a leading provider of
collaborative health care management solutions, today announced
that it has entered into an agreement to deliver its Alineo๏ฟฝ
Collaborative Health Care Management platform to Blue Cross and
Blue Shield of Florida (BCBSF). ๏ฟฝWe are very pleased to work with a
health plan known as a leader,๏ฟฝ said MEDecision Founder and CEO
David St.Clair. ๏ฟฝAlineo will provide BCBSF with a simplified, smart
and state-of-the-art solution that represents some of the most
advanced technology of its kind currently available.๏ฟฝ Alineo is a
collaborative health care management platform for addressing case
management, disease management and utilization management. Through
an innovative, member-centric approach, it analyzes, applies and
automates payer-driven best practices. Alineo enables health plans
to streamline operational efficiencies, reduce waste and increase
care quality by helping them optimally manage risk and compliance,
enhance business agility and control costs. BCBSF will implement
Alineo in a two-phase process that will begin immediately and
continue through 2009. MEDecision introduced Alineo on January 15
as its completely re-architected collaborative health care
management platform comprising a series of individual components,
including: Alineo Reporting, Alineo Correspondence, Alineo
Automated Approvals, Alineo Clinical Criteria, Alineo Clinical
Programs, Alineo Clinical Intelligence, Alineo Clinical Summaries
and Alineo Care Management Analytics. For more information, please
visit www.MEDecision.com. About MEDecision MEDecision offers
collaborative health care management solutions that provide a
simplified and smart way to manage the health of members and member
populations which can improve the quality and affordability of
care. Based on state-of-the-art technology, MEDecision's solutions
include Alineo๏ฟฝ, a collaborative health care management platform
for managing case, disease and utilization management and
Nexalign๏ฟฝ, a collaborative health care information exchange
service. MEDecision believes that, in the aggregate, its health
care payer customers insure or manage care for approximately one in
every six people in the U.S. with health insurance. For more
information, please visit www.MEDecision.com. MEDecision is a
trademark of MEDecision, Inc. The MEDecision logo and product names
are also trademarks or registered trademarks of MEDecision, Inc.
Other product and brand names are trademarks of their respective
owners. MEDE-G
Medecision (MM) (NASDAQ:MEDE)
๊ณผ๊ฑฐ ๋ฐ์ดํฐ ์ฃผ์ ์ฐจํธ
๋ถํฐ 1์(1) 2025 ์ผ๋ก 2์(2) 2025
Medecision (MM) (NASDAQ:MEDE)
๊ณผ๊ฑฐ ๋ฐ์ดํฐ ์ฃผ์ ์ฐจํธ
๋ถํฐ 2์(2) 2024 ์ผ๋ก 2์(2) 2025
Medecision (MM) (๋์ค๋ฅ)์ ์ค์๊ฐ ๋ด์ค: ์ต๊ทผ ๊ธฐ์ฌ 0
More MEDecision, Inc. News Articles